115 related articles for article (PubMed ID: 18890)
1. Chronic neuroleptic therapy: tolerance and GABA systems.
Lloyd KG; Shibuya M; Davidson L; Hornykiewicz O
Adv Biochem Psychopharmacol; 1977; 16():409-15. PubMed ID: 18890
[No Abstract] [Full Text] [Related]
2. The turnover rate of gamma-aminobutyric acid in the nuclei of telencephalon: implications in the pharmacology of antipsychotics and of a minor tranquilizer.
Mao CC; Marco E; Revuelta A; Bertilsson L; Costa E
Biol Psychiatry; 1977 Jun; 12(3):359-71. PubMed ID: 17436
[TBL] [Abstract][Full Text] [Related]
3. Sustained gamma-aminobutyric acid receptor stimulation and chronic neuroleptic effects.
Lloyd KG; Worms P
Adv Biochem Psychopharmacol; 1980; 24():253-8. PubMed ID: 6105780
[No Abstract] [Full Text] [Related]
4. Brain region effects of clozapine on amino acid and monoamine transmission.
Yamamoto BK; Pehek EA; Meltzer HY
J Clin Psychiatry; 1994 Sep; 55 Suppl B():8-14. PubMed ID: 7961581
[TBL] [Abstract][Full Text] [Related]
5. Experimental tardive dyskinesia.
Gunne LM; Häggström JE
J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):48-50. PubMed ID: 2858481
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of gamma-aminobutyric acid (GABA)-elevating agents on the neuroleptic-induced activation of striatal tyrosine-hydroxylase: evidence that di-n-propylacetate augments GABAergic neurotransmission.
Casu M; Gale K
J Pharmacol Exp Ther; 1981 Apr; 217(1):177-80. PubMed ID: 6110774
[TBL] [Abstract][Full Text] [Related]
7. [Effects of risperidone on catalepsy and cerebral dopamine, serotonin and GABA metabolism in the rat: comparison with haloperidol].
Kikumoto O; Okamoto Y; Hayakawa H; Yokota N; Kawai K; Motohashi N; Yamawaki S
Yakubutsu Seishin Kodo; 1993 Feb; 13(1):39-42. PubMed ID: 7686319
[TBL] [Abstract][Full Text] [Related]
8. Application of principles of steady-state kinetics to the estimation of gamma-aminobutyric acid turnover rate in nuclei of rat brain.
Bertilsson L; Mao CC; Costa E
J Pharmacol Exp Ther; 1977 Feb; 200(2):277-84. PubMed ID: 839439
[TBL] [Abstract][Full Text] [Related]
9. Effect of thioridazine, clozapine and other antipsychotics on the kinetic state of tyrosine hydroxylase and on the turnover rate of dopamine in striatum and nucleus accumbens.
Zivkovic B; Guidotti A; Revuelta A; Costa E
J Pharmacol Exp Ther; 1975 Jul; 194(1):37-46. PubMed ID: 239221
[TBL] [Abstract][Full Text] [Related]
10. Effect of chronic neuroleptic or L-DOPA administration on GABA levels in the rat substantia nigra.
Lloyd KG; Hornykiewics O
Life Sci; 1977 Nov; 21(10):1489-96. PubMed ID: 927011
[No Abstract] [Full Text] [Related]
11. Participation of GABA receptors in the short-term activation of striatal tyrosine-3-monooxygenase elicited by neuroleptics.
Guidotti A; Gale K
Adv Biochem Psychopharmacol; 1977; 16():455-60. PubMed ID: 18893
[No Abstract] [Full Text] [Related]
12. [Catalepsy in the rat after haloperidol and some new GABA-ergic agents].
Vamvakidès A
Agressologie; 1984 Oct; 25(9):1011-6. PubMed ID: 6542324
[No Abstract] [Full Text] [Related]
13. Possible involvement of prolactin in sulpiride-induced changes in nigral and striatal GAD activity.
Scapagnini U; Canonico PL; Patti F; Condorelli DF; Nicoletti F
Ann Ist Super Sanita; 1982; 18(1):27-9. PubMed ID: 7171172
[No Abstract] [Full Text] [Related]
14. Dopaminergic receptor activity in substantia nigra in the mechanisms of autoregulation of striatal dopamine release.
Groppetti A; Parenti M; Cattabeni F; Maggi A; De Angelis L; Monduzzi M; Racagni G
Adv Biochem Psychopharmacol; 1978; 19():363-71. PubMed ID: 696464
[No Abstract] [Full Text] [Related]
15. Participation of an endogenous Ca++-blinding protein activator in the development of drug-induced supersensitivity of striatal dopamine receptors.
Gnegy M; Uzunov P; Costa E
J Pharmacol Exp Ther; 1977 Sep; 202(3):558-64. PubMed ID: 19618
[No Abstract] [Full Text] [Related]
16. [Metabolism of dopamine and norepinephrine in rat brain after acute and chronic administration of haloperidol, loxapine and clozapine].
Bürki HR
Arzneimittelforschung; 1974 Jul; 24(7):983-4. PubMed ID: 4136404
[No Abstract] [Full Text] [Related]
17. Dopamine-stimulated adenylate cyclase in rat substantia nigra: localization and effects of neuroleptics.
Spano PF; Di Chiara G; Loddo P; Tonon GC; Trabucchi M
Adv Biochem Psychopharmacol; 1977; 16():613-6. PubMed ID: 18903
[No Abstract] [Full Text] [Related]
18. Dopamine-sensitive adenylate cyclase and receptor binding activities after acute and chronic neuroleptic drug treatment.
Clement-Cormier Y
Adv Biochem Psychopharmacol; 1980; 24():103-11. PubMed ID: 6105768
[No Abstract] [Full Text] [Related]
19. Nonstriatal dopaminergic neurons: Section X. Morphine, amphetamine, and noncataleptogenic neuroleptics: Introduction: morphine, amphetamine, and noncataleptogenic neuroleptics.
Costa E
Adv Biochem Psychopharmacol; 1977; 16():557-63. PubMed ID: 18900
[No Abstract] [Full Text] [Related]
20. Acetylcholine turnover rate in n. accumbens, n. caudatus, globus pallidus, and substantia nigra: action of cataleptogenic and non-cataleptogenic antipsychotics.
Cheney DL; Zsilla G; Costa E
Adv Biochem Psychopharmacol; 1977; 16():179-86. PubMed ID: 18881
[No Abstract] [Full Text] [Related]
[Next] [New Search]
